Knowles (KN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
5 Feb, 2026Executive summary
Completed transformation into a high-margin industrial technology leader, focusing on MedTech, Defense, Industrial, and Energy markets, and exceeding Investor Day expectations.
Q4 2025 revenue rose 14% year-over-year to $162.2 million, surpassing guidance; full-year 2025 revenue was $593.2 million, up 7.2%.
Full-year non-GAAP diluted EPS was $1.11, up 20.7% year-over-year; Q4 non-GAAP EPS was $0.36, up 33%.
Strong cash generation with $114 million net cash from operations for 2025, representing 19.2% of revenues.
Robust backlog, new design wins, and major energy order position the company for continued growth in 2026.
Financial highlights
Q4 2025 gross margin was 51.9% (non-GAAP: 45.3%); full-year non-GAAP gross margin was 44.5%.
Adjusted EBITDA for 2025 was $140.2 million, 23.6% of revenues, up 9% year-over-year.
SG&A expenses in Q4 were $27 million, up $2 million due to higher incentive compensation.
Ended Q4 with $54 million in cash and $114 million in borrowings under the revolving credit facility.
Capital expenditures for 2025 were $32.1 million, or 5.4% of revenues.
Outlook and guidance
Q1 2026 revenue guidance: $143–$153 million; non-GAAP diluted EPS expected between $0.22 and $0.26.
Q1 2026 adjusted EBIT margin projected at 18%-20%; R&D expenses expected between $9 million and $11 million; SG&A between $25 million and $27 million.
2026–2029 targets: 8–10% revenue CAGR, 10–14% adjusted EBITDA CAGR, and 16–20% cash from operations as a percentage of revenue.
Full-year capital spending to support capacity expansion, especially for large energy orders.
Positioned for continued strong organic revenue growth above historic levels in 2026.
Latest events from Knowles
- Annual meeting covers director elections, executive pay, and auditor ratification for 2026.KN
Proxy Filing11 Mar 2026 - 2026 proxy covers director elections, executive pay, auditor ratification, and robust governance.KN
Proxy Filing11 Mar 2026 - Clean energy and climate/sustainability drive growth as portfolio streamlining boosts margins.KN
Barclays 43rd Annual Industrial Select Conference17 Feb 2026 - Portfolio shift to MedTech, defense, and industrial boosts margins and growth outlook.KN
2024 Southwest IDEAS Conference3 Feb 2026 - Targets 8–10% annual revenue growth and 10–14% EBITDA growth through organic and M&A strategies.KN
Investor Day 20253 Feb 2026 - Q2 revenue up 18.3% to $204.7M; $249.4M goodwill impairment drove $259M net loss.KN
Q2 20242 Feb 2026 - Q3 revenue up 32% year-over-year; strategic divestiture and margin gains position for growth.KN
Q3 202418 Jan 2026 - Q1 2025 revenue hit $132.2M, with strong cash flow and robust Precision Devices demand.KN
Q1 202526 Dec 2025 - 2024 revenue up 21% and non-GAAP EPS up 32%, with strong cash flow and major new orders.KN
Q4 202423 Dec 2025